WO2026087594 - ANTIMICROBIAL POTENTIAL OF PROBIOTICS AGAINST HUMAN PATHOGENS
National phase entry is expected:
Publication Number
WO/2026/087594
Publication Date
30.04.2026
International Application No.
PCT/EP2025/080496
International Filing Date
22.10.2025
Title **
[English]
ANTIMICROBIAL POTENTIAL OF PROBIOTICS AGAINST HUMAN PATHOGENS
[French]
POTENTIEL ANTIMICROBIEN DE PROBIOTIQUES CONTRE DES PATHOGÈNES HUMAINS
Applicants **
INTERNATIONAL N&H DENMARK APS
Inventors
LILJAVIRTA, Jenni M.
LAITILA, Arja
LATVALA, Sinikka Anneli
LEHTINEN, Markus
LEHTORANTA, Liisa
MAUKONEN, Pia Johanna M.
OUWEHAND, Arthur
ANJUM, Mehreen
KOSKELA, Terhi
LAPPALAINEN, Anna
Priority Data
24208926.6
25.10.2024
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1993 | |
| EPO | Filing, Examination, Granting | 8118 | |
| Japan | Filing, Examination, Granting | 2140 | |
| South Korea | Filing, Examination, Granting | 1983 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
18,974
Contact Us
Abstract[English]
The present invention relates to pure cultures of strains of the family Lactobacillaceae or of the genus Bifidobacterium as well as next-generation probiotic for use as antimicrobials for inhibiting growth of a bacterium, such as infectious bacteria or a bacterium under infections conditions. Furthermore, the present invention relates to a substance or composition comprising such substantially pure cultures of strains of the family Lactobacillaceae or of the genus Bifidobacterium or of a next-generation probiotic, as well as to methods of treating a bacterial infection in mammals by administering such strains of the family Lactobacillaceae or of the genus Bifidobacterium or of a next-generation probiotic.[French]
La présente invention concerne des cultures pures de souches de la famille des Lactobacillaceae ou du genre Bifidobacterium, ainsi que des probiotiques de nouvelle génération destinés à être utilisés en tant qu'agents antimicrobiens pour inhiber la croissance d'une bactérie, telle que des bactéries infectieuses ou une bactérie dans des conditions d'infections. En outre, la présente invention concerne une substance ou une composition comprenant de telles cultures sensiblement pures de souches de la famille des Lactobacillaceae ou du genre Bifidobacterium ou d'un probiotique de nouvelle génération, ainsi que des méthodes de traitement d'une infection bactérienne chez des mammifères par administration de telles souches de la famille des Lactobacillaceae ou du genre Bifidobacterium ou d'un probiotique de nouvelle génération.